- Home
- MCRB vs MED Comparison
MCRB vs MED Comparison
Compare MCRB & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- MED
- Stock Information
- Founded
- MCRB 2010
- MED 1980
- Country
- MCRB United States
- MED United States
- Employees
- MCRB N/A
- MED N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- MED Packaged Foods
- Sector
- MCRB Health Care
- MED Consumer Staples
- Exchange
- MCRB Nasdaq
- MED Nasdaq
- Market Cap
- MCRB 141.9M
- MED 139.0M
- IPO Year
- MCRB 2015
- MED N/A
- Fundamental
- Price
- MCRB $0.37
- MED $11.92
- Analyst Decision
- MCRB Hold
- MED Hold
- Analyst Count
- MCRB 5
- MED 1
- Target Price
- MCRB $4.00
- MED $16.50
- AVG Volume (30 Days)
- MCRB 1.3M
- MED 253.6K
- Earning Date
- MCRB 05-07-2025
- MED 04-28-2025
- Dividend Yield
- MCRB N/A
- MED N/A
- EPS Growth
- MCRB N/A
- MED N/A
- EPS
- MCRB 0.00
- MED 0.19
- Revenue
- MCRB N/A
- MED $602,463,000.00
- Revenue This Year
- MCRB N/A
- MED N/A
- Revenue Next Year
- MCRB N/A
- MED N/A
- P/E Ratio
- MCRB $474.36
- MED $62.74
- Revenue Growth
- MCRB N/A
- MED N/A
- 52 Week Low
- MCRB $0.46
- MED $11.88
- 52 Week High
- MCRB $1.53
- MED $36.30
- Technical
- Relative Strength Index (RSI)
- MCRB 28.34
- MED 32.66
- Support Level
- MCRB $0.36
- MED $11.88
- Resistance Level
- MCRB $0.67
- MED $13.54
- Average True Range (ATR)
- MCRB 0.07
- MED 0.64
- MACD
- MCRB -0.02
- MED -0.09
- Stochastic Oscillator
- MCRB 2.71
- MED 2.03
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.